Tags: HematologyBreast Cancer
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | <em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. | Circumventing Cancer Resistance - 9 days ago New Research Avenues Provide Hope for Metastatic Disease - 9 months ago | |
| 2 | <em>The Scientist</em> The Scientist Exploring Life, Inspiring Innovation. | What Drives Myeloid Cell Responses to Disease - 10 days ago | |
| 3 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | ||
| 4 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | Arcellx to present positive data on multiple myeloma treatments - about 2 months ago Scotland first in UK to approve new myeloma treatment - 4 months ago | |
| 5 | Ryan Haumschild, PharmD, MS, MBA Pharmacy Times Director of Pharmacy. Editorial Board member. Atlanta, Georgia | Operationalizing Bispecific Therapy and the Impact of CAR-T Advancements on Sequencing - about 1 month ago Current Landscape of Bispecific Therapies for RRMM - about 1 month ago | |
| 6 | Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA | Final Thoughts - about 1 month ago Personalizing Treatments and Patient Education - about 2 months ago Challenges in Adopting Novel Therapies - 2 months ago Real-World Considerations for New Therapies - 2 months ago Impact of Transplant Eligibility on Treatment Selection - 3 months ago | |
| 7 | Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts | ||
| 8 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 9 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | All-Oral Therapy Promising in Higher-Risk MDS, CMML - 11 months ago Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS - about 1 year ago | |
| 10 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 6 months ago Why Some Myeloma Patients Refuse Stem Cell Transplant - about 1 year ago |